Skip to Main Content

Paper Details

Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohort.
Transl Androl Urol
0
2022

Datasets

Release 1.2